New research at the Roy Blunt NextGen Precision Health building has discovered a potential treatment for an underlying cause of cardiovascular disease in people with Type 2 diabetes.
Merck CEO says he’s confident in growth despite Gardasil ‘headwind’
Despite uncertainty around HPV vaccine sales in China, Merck CEO Rob Davis said he’s confident the company can “deliver strong growth” and navigate Keytruda’s impending